Retour
Fourchette du Jour
28,20 €
30,26 €
Fourchette 52 Semaines
13,70 €
36,03 €
Volume
117 346
Moyenne 50J / 200J
24,16 €
/
20,94 €
Clôture Précédente
29,44 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -7,6 | 0,3 |
| P/B | 2,3 | 2,9 |
| ROE % | -37,8 | 3,7 |
| Net Margin % | — | 3,8 |
| Rev Growth 5Y % | — | 10,0 |
| D/E | 0,0 | 0,2 |
Objectif de Cours des Analystes
Hold
60,00 €
+99.5%
BPA Prévisionnel
-4,85 €
CA Est.
0
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
-4,19 €
-4,19 € – -4,19 €
|
140 M | 6 |
| FY2029 |
-6,29 €
-6,29 € – -6,29 €
|
42 M | 6 |
| FY2028 |
-5,61 €
-9,35 € – -2,25 €
|
0 | 8 |
Points Clés
Debt/Equity of 0,01 — conservative balance sheet
Negative free cash flow of -60,29M
Croissance
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
-37,82%
ROIC-24,95%
Net MarginN/A
Op. MarginN/A
Sécurité
Debt / Equity
0,01
Current Ratio26,63
Interest Coverage-1333,90
Valorisation
P/E Ratio
-7,61
P/B Ratio2,25
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0,0 | Net Income (TTM) | -74,15M |
| ROE | -37,82% | ROA | -28,41% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -60,29M |
| ROIC | -24,95% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,01 | Current Ratio | 26,63 |
| Interest Coverage | -1333,90 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -7,61 | P/B Ratio | 2,25 |
| P/S Ratio | N/A | PEG Ratio | -1,69 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 564,61M | Enterprise Value | 312,09M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0,0 | 0,0 | 0,0 | 0,0 | 0,0 |
| Net Income | -74,15M | -57,98M | -42,82M | -32,18M | -8,93M |
| EPS (Diluted) | -4,05 | -3,93 | -11,53 | -29,05 | -33,36 |
| Gross Profit | 0,0 | 0,0 | 0,0 | 0,0 | 0,0 |
| Operating Income | -84,04M | -58,02M | -44,65M | -32,83M | -15,61M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 261,04M | 152,91M | 39,40M | 47,21M | 32,88M |
| Total Liabilities | 9,71M | 12,13M | 124,04M | 92,86M | 47,84M |
| Shareholders' Equity | 251,33M | 140,78M | -84,64M | -45,65M | -14,96M |
| Total Debt | 1,28M | 3,30M | 4,34M | 5,79M | 1,06M |
| Cash & Equivalents | 253,80M | 141,24M | 28,77M | 35,97M | 28,06M |
| Current Assets | 257,36M | 146,86M | 30,88M | 37,04M | 28,62M |
| Current Liabilities | 9,67M | 11,61M | 40,89M | 7,84M | 4,12M |